ArticleDiscover oncology2023

Impact of primary resistance to front-line targeted therapy in metastatic renal cell carcinoma on subsequent immune-checkpoint-inhibition.

J H Börner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.